These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35843873)

  • 1. In Situ Antigen-Capturing Nanochaperone Toward Personalized Nanovaccine for Cancer Immunotherapy.
    Li X; Zhang Y; Wu X; Chen J; Yang M; Ma F; Shi L
    Small; 2022 Aug; 18(32):e2203100. PubMed ID: 35843873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Refolding of Denatured IL-12 Using In Situ Antigen-Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy.
    Zhang Y; Ma F; Chen J; Chen Y; Xu L; Li A; Liu Y; Ma R; Shi L
    Adv Mater; 2024 May; 36(19):e2309927. PubMed ID: 38387609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimetic Heat Shock Protein Mediated Immune Process to Enhance Cancer Immunotherapy.
    Li X; Cai X; Zhang Z; Ding Y; Ma R; Huang F; Liu Y; Liu J; Shi L
    Nano Lett; 2020 Jun; 20(6):4454-4463. PubMed ID: 32401534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy.
    Zhang S; Feng Y; Meng M; Li Z; Li H; Lin L; Xu C; Chen J; Hao K; Tang Z; Tian H; Chen X
    Biomaterials; 2022 Oct; 289():121794. PubMed ID: 36113330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nanovaccine Based on Adjuvant Peptide FK-13 and l-Phenylalanine Poly(ester amide) Enhances CD8
    Xie C; You X; Zhang H; Li J; Wang L; Liu Y; Wang Z; Yao R; Tong T; Li M; Wang X; Cui L; Zhang H; Guo H; Li C; Wu J; Xia X
    Adv Sci (Weinh); 2023 Jul; 10(20):e2300418. PubMed ID: 37162249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
    Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.
    Kim H; Khanna V; Kucaba TA; Zhang W; Ferguson DM; Griffith TS; Panyam J
    Mol Pharm; 2019 Mar; 16(3):1200-1210. PubMed ID: 30620878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Situ Cocktail Nanovaccine for Cancer Immunotherapy.
    Liu M; Xie D; Hu D; Zhang R; Wang Y; Tang L; Zhou B; Zhao B; Yang L
    Adv Sci (Weinh); 2023 Nov; 10(31):e2207697. PubMed ID: 37740439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An MRI-trackable therapeutic nanovaccine preventing cancer liver metastasis.
    Xiao B; Li D; Xu H; Zhou X; Xu X; Qian Y; Yu F; Hu H; Zhou Z; Liu X; Gao J; Slater NKH; Shen Y; Tang J
    Biomaterials; 2021 Jul; 274():120893. PubMed ID: 34029913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Nanovaccine Coated with Calcinetin-Expressed Cancer Cell Membrane Antigen for Cancer Immunotherapy.
    Xiong X; Zhao J; Pan J; Liu C; Guo X; Zhou S
    Nano Lett; 2021 Oct; 21(19):8418-8425. PubMed ID: 34546061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer.
    Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H
    Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy.
    Yang W; Zhu G; Wang S; Yu G; Yang Z; Lin L; Zhou Z; Liu Y; Dai Y; Zhang F; Shen Z; Liu Y; He Z; Lau J; Niu G; Kiesewetter DO; Hu S; Chen X
    ACS Nano; 2019 Mar; 13(3):3083-3094. PubMed ID: 30835435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy.
    Gao ZL; Xu W; Zheng SJ; Duan QJ; Liu R; Du JZ
    Nano Lett; 2023 Mar; 23(5):1904-1913. PubMed ID: 36801829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Targetable pH-Sensitive Zinc-Based Immunomodulators Combined with Photodynamic Therapy for
    Shin H; Na K
    ACS Biomater Sci Eng; 2020 Jun; 6(6):3430-3439. PubMed ID: 33463185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring a Nanochaperone to Regulate α-Synuclein Assembly.
    Wu X; Ma F; Pan BB; Zhang Y; Zhu L; Deng F; Xu L; Zhao Y; Yin X; Niu H; Su XC; Shi L
    Angew Chem Int Ed Engl; 2022 May; 61(19):e202200192. PubMed ID: 35229425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy.
    Qin YT; Liu XH; An JX; Liang JL; Li CX; Jin XK; Ji P; Zhang XZ
    ACS Nano; 2023 Dec; 17(24):24947-24960. PubMed ID: 38055727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors.
    Kleinovink JW; van Driel PB; Snoeks TJ; Prokopi N; Fransen MF; Cruz LJ; Mezzanotte L; Chan A; Löwik CW; Ossendorp F
    Clin Cancer Res; 2016 Mar; 22(6):1459-68. PubMed ID: 26546617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
    Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
    Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-like nanomedicine for cancer immunotherapy.
    Yi Y; Yu M; Li W; Zhu D; Mei L; Ou M
    J Control Release; 2023 Mar; 355():760-778. PubMed ID: 36822241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.